Evaluating the effectiveness of adding probiotic supplements to standard treatment in the treatment process of pregnant women with COVID-19: a double-blind randomized clinical trial

Rasht University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新: 2022年1月11日

适应症

试验速览

暂无简介。

•Pregnant women with mild / moderate COVID-19 hospitalization in Al-Zahra Hospital in Rasht
•Diagnosis based on a positive PCR or antigen test results
•Hospitalization on the day of admission
•Onset of Covid symptoms up to 5 days before admission to the study
•Gestational age>12 weeks
•Age= 16 years
•fever (oral temperature =37.2 ° C)
•Having at least one of the criteria of respiratory rate=24 per minute or oxygen saturation < 93 (without oxygen) Pa2 / Fi2
•Completion of informed consent form

•Existence of any obstetric problems such as premature rupture of the amniotic membrane, placental abruption
•History of receiving probiotic supplement for up to one week before enrollment
•Presence of underlying diseases and gastrointestinal disorders such as IBD
•Presence chronic diseases under treatment (such as asthma and allergies, heart failure) and acquired or congenital immunodeficiencies

发起方

Rasht University of Medical Sciences